Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism DAAO inhibitors(D-amino-acid oxidase inhibitors), NMDA receptor agonists(Glutamate [NMDA] receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Schizophrenia, Treatment-Resistant | Phase 2 | TW | 01 Oct 2014 |